Laimei Pharmaceutical (300006.SZ) obtained the drug registration certificate for injectable nicordil (specification: 2mg, 12mg)

Zhitongcaijing · 03/11 07:49

Zhitong Finance App News, Lemei Pharmaceutical (300006.SZ) issued an announcement. Recently, the company received the “Drug Registration Certificate” approved and issued by the State Drug Administration for injectable Nicodyl in the form of 2 mg and 12 mg.

Nicordil for injection is mainly used for unstable angina pectoris and acute heart failure, improves coronary microcirculation, can effectively reduce cardiovascular events, and can significantly reduce the risk of acute coronary syndrome. Clinical patients benefit a lot.

This time, the company obtained the “Drug Registration Certificate” for injectable Nicodyl (specification: 2 mg, 12 mg), which is conducive to further enriching the company's product line.